Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)

for
Breast Lesions
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation

Sex: Female

Age: 18+

Code: NCT01368939

Recruiting

Autologous CAR-T Cells Targeting B7-H3 in PDAC

for
Pancreas Cancer, Relapse, Resistant Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06158139

Phase 1, Recruiting

BREAST Choice Decision Tool R21 - AIM2

for
Breast Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06817226

Recruiting

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

for
Solid Tumors, Hematological Malignancies
Location: Providence RI, East Greenwich RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT02213822

Recruiting

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

for
Solid Tumors, Adult
Location: Irving TX, San Antonio TX
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Sex: All

Age: 18+

Code: NCT06504368

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies

for
Cancer, Tumor, Solid, Refractory Cancer
Location: Los Angeles CA
Sponsor: Taiga Biotechnologies, Inc.

Sex: All

Age: 18+

Code: NCT04640246

Phase 1, Phase 2, Recruiting

Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12

for
Breast Cancer
Location: Las Vegas NV
Sponsor: University of Nevada, Las Vegas

Sex: All

Age: 18 - 70

Code: NCT01679223

Recruiting

Circadian Thermal Sensing to Detect Breast Disease

for
Early-Stage Breast Carcinoma
Location: Mountain View CA
Sponsor: Cyrcadia Health

Sex: Female

Age: 21+

Code: NCT02511301

Phase 1, Phase 2, Recruiting

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial

for
Breast Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: Female

Age: 18+

Code: NCT06444269

Phase 2, Recruiting

Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor

for
Metastatic Cancer
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 18+

Code: NCT00107367

Phase 1, Phase 2, Recruiting

Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy

for
Breast Cancer, High Risk of Breast Cancer
Location: Dallas TX
Sponsor: Deborah Farr, MD

Sex: Female

Age: 18 - 70+

Code: NCT05245812

Recruiting

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

for
Cancer
Location: Philadelphia PA
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 0 - 18

Code: NCT00491946

Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

for
Biliary Tract Cancer, Breast Cancer, Cervical Cancer,
Location: Boston MA, Miami FL, Denver CO, Nashville TN,
Sponsor: ModeX Therapeutics, An OPKO Health Company

Sex: All

Age: 18+

Code: NCT06239194

Phase 1, Phase 2, Recruiting

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

for
Solid Tumor
Location: Rochester MN, San Antonio TX, Phoenix AZ
Sponsor: Athenex, Inc.

Sex: All

Age: 18+

Code: NCT02963168

Phase 1, Recruiting

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib

for
Breast Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: Female

Age: 18+

Code: NCT04614194

Phase 2, Recruiting

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

for
Advanced Solid Tumor Cancer
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Calico Life Sciences LLC

Sex: All

Age: 18+

Code: NCT04777994

Phase 1, Recruiting

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

for
Obesity, Malignant Neoplasm
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 13 - 30

Code: NCT04453072

Recruiting

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT00992303

Recruiting

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

for
Hormone Receptor-positive Breast Cancer,
Location: Boston MA, Fairfax VA, Tampa FL, Detroit MI,
Sponsor: Ellipses Pharma

Sex: Female

Age: 18+

Code: NCT05573126

Phase 1, Phase 2, Recruiting

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

for
Breast Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 0+

Code: NCT00897065

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial